Legal status · United States
Is Dasatinib legal in the United States?
Yes. Dasatinib is an approved medicine in the United States, classified as "FDA-approved (for its labeled use), prescription only". Approval covers its labeled indication and it is supplied on prescription, not over the counter. Products labeled "research use only" fall outside that approval and the label does not make human use lawful. Human evidence: Preliminary.
Dasatinib in the United States at a glance
| Classification | FDA-approved (for its labeled use), prescription only |
|---|---|
| FDA approval status | FDA-approved for leukemia; senolytic use is off-label and investigational |
| Evidence level | Preliminary (research strength: Moderate) |
| Reviewed | Sep 2026 |
Classification and note come from the Dasatinib profile, checked against U.S. Food and Drug Administration (FDA) listings at the reviewed date.
What this means
- 01
FDA has approved Dasatinib for at least one labeled indication, so a pharmaceutical-grade product exists in the United States and is dispensed on prescription.
- 02
Approval is indication-specific. Uses outside the label are a clinical decision for a prescriber, not something the approval itself authorizes.
- 03
Unlicensed online vials, including those labeled "research use only", are not the approved product and are not covered by the approval.
What Dasatinib is
An FDA-approved leukemia drug repurposed in research as a senolytic, most often combined with quercetin to clear senescent cells.
Dasatinib is a kinase inhibitor approved as Sprycel for certain leukemias. In longevity research it is repurposed as a senolytic, clearing senescent cells, and is studied in the 'D+Q' combination with quercetin for conditions linked to cellular aging such as diabetic kidney disease and lung fibrosis.
Mechanism: Inhibits survival signaling in senescent cells, triggering their death, especially alongside quercetin.
Regulatory history: FDA-approved for leukemia; senolytic use is off-label and investigational
How FDA treats this kind of product
Approves prescription drugs by indication and polices unapproved products, including peptides sold online. Compounding pharmacies may prepare some compounds under a prescription when the FDA places them on a permitted bulk-substances category.
The classification above is the The Longevity Archive reading of U.S. Food and Drug Administration listings for Dasatinib at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Dasatinib in other countries
United Kingdom
Approved medicineLicensed (for its labeled use), prescription only
Is Dasatinib legal in the United Kingdom?Australia
Approved medicineTGA-registered (for its labeled use), prescription only
Is Dasatinib legal in Australia?Canada
Approved medicineHealth Canada approved (for its labeled use), prescription only
Is Dasatinib legal in Canada?Frequently asked questions
Is Dasatinib legal in the United States?
Yes. Dasatinib is an approved medicine in the United States, classified as "FDA-approved (for its labeled use), prescription only". Approval covers its labeled indication and it is supplied on prescription, not over the counter. Products labeled "research use only" fall outside that approval and the label does not make human use lawful. Human evidence: Preliminary.
Can I buy Dasatinib in the United States?
Only with a prescription. Dasatinib is classified as "FDA-approved (for its labeled use), prescription only" in the United States, so it is dispensed by pharmacies against a prescription for its approved indication. Buying it from unlicensed online sellers or as a "research chemical" is outside that system and carries no regulatory protection.
Is Dasatinib FDA approved?
Yes. FDA status: FDA-approved for leukemia; senolytic use is off-label and investigational. Current US classification: "FDA-approved (for its labeled use), prescription only". Evidence level: Preliminary.
Related compounds in the United States
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Dasatinib live on its compound profile.
Dasatinib profileThis page is general information about the regulatory status of Dasatinib in the United States, current as of Sep 2026. It is not legal advice, and classifications change; check U.S. Food and Drug Administration directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.